Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2007-01-30
2007-01-30
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S203100, C424S234100, C424S250100, C424S238100, C424S194100, C424S184100, C424S831000, C424S832000, C514S023000, C536S123100
Reexamination Certificate
active
10643349
ABSTRACT:
The present invention pertains generally to novelNeisseria meningitidisserogroup B glycoconjugates. More particularly, the invention pertains to glycoconjugates formed from aNeisseria meningitidisserogroup B capsular oligosaccharide derivative (MenB OS derivative) in which sialic acid residue N-acetyl groups are replaced with N-acyl groups. The invention also pertains to vaccine formulations containing the glycoconjugates, methods of making the vaccine formulations, and methods of using the vaccine formulations to treat or preventNeisseria meningitidisserogroup B orE. coliK1 disease in a mammalian subject.
REFERENCES:
patent: 4727136 (1988-02-01), Jennings et al.
patent: 5034519 (1991-07-01), Beuvery et al.
patent: 5153312 (1992-10-01), Porro
patent: 5354853 (1994-10-01), Staveski et al.
patent: 5576002 (1996-11-01), Jennings et al.
patent: 5623057 (1997-04-01), Marburg et al.
patent: 5683699 (1997-11-01), Jennings et al.
patent: 5811102 (1998-09-01), Jennings et al.
patent: 5847112 (1998-12-01), Kniskern et al.
patent: 5902586 (1999-05-01), Jennings et al.
patent: 5969130 (1999-10-01), Jennings et al.
patent: 6030619 (2000-02-01), Granoff et al.
patent: 6048527 (2000-04-01), Granoff et al.
patent: 6413520 (2002-07-01), Granoff
patent: 6638513 (2003-10-01), Seid
patent: 0 208 375 (1987-01-01), None
patent: 0 497 525 (1992-08-01), None
patent: 0 504 202 (1995-05-01), None
patent: WO 91/08772 (1991-06-01), None
patent: WO 96/14086 (1996-05-01), None
patent: WO 96/40225 (1996-12-01), None
Ala'Aldeen, “Vaccines againstNeisseria meningitidis: past, present and future,”Biotecnologia Applicada13:1-7, 1996.
Anderson et al.,J. Immunol.142:2464-2468, 1989.
Ashwell et al.,Anal. Biochem.222:495-502, 1994.
Bartoloni et al., “Murine monoclonal antibodies to an N-propionylated meningococcal B polysaccharide exhibit heterogencity with respect to cross-reactivity with N-acetylated meningococcal B polysaccharide and autoreactivity to host polysialyated glycoproteins,”.
Baumann et al.,Biochemistry32:4007-4013, 1993.
Boyer et al.,Ped. Infect. Dis. J.12:779-780, 1993.
Brisson et al., “Helical epitope of the group B meningoccoccal α(2-8)-linked sialic acid polysaccaride,”Biochemistry31:4996-5004, 1992.
Costantino et al., Vaccine 10:691-698, 1992.
Devi et al.,Infect. Immun.59:732-736, 1991.
Egan et al.,J. Am. Med. Assoc.273:888-889, 1995.
Frasch, “Meningococcal vaccines: past, present and future,” inMeningococcal Disease(edited by Keith Cartwright 1995) pp. 245-283, 1995.
Garner et al.,Contrib. Microbiol. Immunol.10:11-17, 1989.
Hallenbeck et al.,J. Biol. Chem.262:3553-3561, 1987.
Jennings et al., “Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group BNeisseria MeningitidisandEscherichia coliK1,”J. Immunology142(10):3585-3591, 1989.
Jennings et al., “Induction of Meningococcal group B polysaccharide-specific IgG antibodies in mice by using a N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine,”J. Immunology137(5):1708-1713, 1986.
Jennings et al., “The capsular polysaccharie of group BNeisseria meningitidisas a vehicle for vaccine development,”Contrib. Microbiol. Immunol. Basel. Karger10:151-165, 1989.
Jennings et al., “Immunochemistry of groups A, B, and C Meningococcal polysaccharide-tetanus toxoid conjugates,”J. Immunology127(3):1011-1018, 1981.
Jennings et al., in Neoglycoconjugates: Preparation and Applications, Y.C. Lee et al. (Ed.) Academic Press, London, pp. 325-371, 1994.
Jennings et al., “N-propionylated group B Meningococcal polysaccharide mimics a unique epitopc on group BNeisseria meningitidis,” J. Exp. Med.165:1207-1211, 1987.
Jennings et al., “Polysialic acid vaccines against Meningitis caused byNeisseria meningitidesandEscherichia coliK1,”Polysiolic Acid, pp. 25-38, 1993.
Jennings et al.,J. Immunol.134:2651-2657, 1985.
Kitazume et al.,Anal. Biochem.202:25-34, 1992.
Lifely et al., Carbohydr. Res. 156:123-135 (abstract), 1986.
Livingston et al.,J. Biol. Chem.263:9443-9448, 1988.
Mandrell et al., “Complement-mediated bactericidal activity of human antibodies to poly α2-<8 N-acetylneuraminic acid, the capsular polysaccharide ofNeisseria meningitidisserogroup B,”J. Infectious Diseases172:1279-1289, 1995.
Michon et al., “Conformational differences between linear α(2-<8)-linked homosialooligosaccharides and the epitope of the group B Meningococcal polysaccharide,”Biochemistry26:8399-8405, 1987.
Paoletti et al.,J. Biol. Chem.265:18278-18283, 1990.
Paoletti et al., J. Clin. Invest. 89:203-209, 1992.
Pon et al.,J. Exp. Med.185:1929-1938, 1997.
Poolman, “Development of a Meningococcal vaccine,”Infectious Agents and Disease4:13-28, 1995.
Porro et al., Medecine Tropicale 43:129-132, 1983.
Roy et al.,Glycoconjugate J.7:3-12, 1990.
Sato et al.,J. Biol. Chem.270:18923-18928, 1995.
Tomlinson et al.,J. Virology55:374-378, 1985.
Pon et al., “N-Propionylated Group B Meningococcal Polysaccharide Mimics a Unique Bactericidal Capsular Epitope in Group BNeisseria meningitidis,” J. Exp. Med., 185(11):1929-1938, 1997.
Chiron Srl
Devi S.
Harbin Alisa A.
Hessler Amy L.
Robins Roberta L.
LandOfFree
Neisseria meningitidis serogroup B glycoconjugates and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neisseria meningitidis serogroup B glycoconjugates and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neisseria meningitidis serogroup B glycoconjugates and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3745582